Vpriv

(velaglucerase alfa)

VPRIV 400 UNT Injection

NO BLACK BOX WARNING

Dosage & administration

* Recommended Starting Dose in Adults and Pediatric Patients 4 Years of Age or Older:
* Patients Naïve to Enzyme Replacement Therapy: 60 Units/kg
* Patients being treated with stable imiglucerase dosages for Gaucher disease: Can switch to VPRIV at previous imiglucerase dose two weeks after last imiglucerase dose

* Determine number of vials to be reconstituted based on patient's actual weight and prescribed dose
* Supplied VPRIV lyophilized powder must be reconstituted with Sterile Water for Injection
* Reconstituted VPRIV solution must be diluted in 100 mL of 0.9% Sodium Chloride Injection prior to intravenous infusion
* Administer the diluted VPRIV solution through an in-line low protein-binding 0.2 or 0.22 µm filter

drug label

Vpriv prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Vpriv prior authorization resources

Most recent Vpriv prior authorization forms

View By Payer

Verified: Oct 02, 2023Blue Cross Blue Shield of Michigan - FEP Vpriv Prior Authorization Form (Medical Benefit)

Verified: Sep 27, 2023Cigna - Enzyme Replacement Therapy Prior Authorization Form

Verified: Sep 26, 2023Blue Cross Blue Shield of Michigan - ERT Prior Authorization Form (Medical Benefit)

Verified: Sep 21, 2023Aetna - Medicare Part B Vpriv Prior Authorization Form

Verified: Sep 21, 2023Aetna - Vpriv Prior Authorization Form

Learn More

Benefits investigation

PDFVpriv One Path Start Form

PDFVpriv One Path Start Form - Spanish

Learn More

financial assistance

Vpriv financial assistance options

Co-pay savings program

commercial only

PDFVpriv One Path Start Form

PDFVpriv One Path Start Form - Spanish

OTHEREnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

PDFVpriv One Path Start Form

PDFVpriv One Path Start Form - Spanish

OTHERBridge (Quickstart) Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

patient education

Vpriv patient education

Getting started on Vpriv

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link